
Most individuals tolerate GLP-1 medication well. The most common side effects are gastrointestinal and typically occur during dose escalation.These may include:
Symptoms are usually mild to moderate and often improve as the body adjusts.
We provide structured guidance to support tolerability, including:
Where clinically appropriate, additional medication may be prescribed to manage side effects.Dose escalation will not proceed if tolerability is poor.
If side effects are:
The dose may be maintained, reduced or temporarily paused pending clinical review.Patient safety takes priority over rapid dose progression.
Clear guidance is provided on red flag symptoms requiring urgent medical assessment, including:
RE Medical Services is not an emergency provider. Patients should seek urgent NHS care where appropriate.
All reported adverse effects are documented and reviewed within our clinical governance framework.
Significant or unexpected reactions may be reported to the relevant regulatory authorities in accordance with professional standards.